The impact of UGT2B7 C802T and CYP3A4*1G polymorphisms on pain relief in cancer patients receiving oxycontin
ConclusionThe palliative effect of oxycontin is better in patients withUGT2B7 802CC than in those with802TT.CYP3A4*1G SNP is unlikely to affect pain relief efficacy of oxycontin.
Source: Supportive Care in Cancer - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | China Health | Oxycodone | OxyContin | Pain | Palliative | Study